Nadolol in Pregnancy: A medical student’s reflection on her pregnancy

Hypertension is a common concern during pregnancy. Beta-blockers are one potential treatment, but third trimester exposure has correlated with an increased risk of perinatal events. Nadolol, a nonselective beta blocker, has properties that differ from those of its selective counterparts, including l...

Full description

Saved in:
Bibliographic Details
Published inMarshall journal of medicine Vol. 4; no. 4; pp. 1 - 21
Main Authors King-Mallory, Rebecca, Barker, Shawndra, McGrogan, Kaitlin, Franks, Adam M.
Format Journal Article
LanguageEnglish
Published Marshall University 01.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hypertension is a common concern during pregnancy. Beta-blockers are one potential treatment, but third trimester exposure has correlated with an increased risk of perinatal events. Nadolol, a nonselective beta blocker, has properties that differ from those of its selective counterparts, including longer half-life, decreased protein binding, and renal excretion in the unchanged form. There is very limited data on the use of nadolol during pregnancy, and its safety has not been completely evaluated. This case study documents the perinatal outcomes of nadolol use throughout a medical student’s pregnancy and explores the experience in obtaining and undergoing medical care.
ISSN:2379-9536
2379-9536
DOI:10.18590/mjm.2018.vol4.iss4.5